Abstract | A host can evolve two types of defence mechanism to increase its fitness when challenged with a pathogen: resistance and tolerance. Immunology is a well-defined field in which the mechanisms behind resistance to infection are dissected. By contrast, the mechanisms behind the ability to tolerate infections are studied in a less methodical manner. In this Opinion, we provide evidence that animals have specific tolerance mechanisms and discuss their potential clinical impact. It is important to distinguish between these two defence mechanisms because they have different pathological and epidemiological effects. An increased understanding of tolerance to pathogen infection could lead to more efficient treatments for infectious diseases and a better description of host-pathogen interactions. 
When immunologists study infections, we often assume that the host's defence strategy involves mechanisms that directly attack the pathogen to block invasion or eliminate the invading microorganism. However, the host can also defend itself by limiting the damage that is caused by the infection. Resistance is defined as the ability to limit pathogen burden, whereas tolerance is defined as the ability to limit the health impact of a given pathogen burden. Tolerance includes all of the mechanisms that regulate the self-harm that can be caused by an immune response (known as bystander damage or immunopathology) and other mechanisms that are not directly related to immune resistance. The sum of resistance and tolerance defines a host's defensive capacity. Although a great deal is known about the molecular mechanisms that are used to kill pathogens and prevent infection, a systematic understanding of how a host regulates the production, repair and avoidance of the damage that accumulates during an infection is limited. By broadening the scope of our studies, we should be able to identify more of these tolerance mechanisms, which could aid the diagnosis and treatment of patients. In this Opinion article, we propose that we can provide a structure for this emerging field by borrowing some concepts from evolutionary biology.
Resistance and tolerance in plants
The concept of a two-component defence response -involving resistance and tolerance -is well described by plant ecologists to assess plant health in pathogen-plant interactions [1] [2] [3] [4] [5] . Reaction norms are a measurement of the phenotypes for a given genotype across a range of environments and they are used in the fields of ecology and evolutionary biology to measure how an individual responds to a range of environmental conditions (FIG. 1) . Plant ecologists have adapted this method to assess the fitness of a plant (for example, in terms of seed production) in response to a measurement of pathogen load, be it the damage that is induced by the pathogen or the host response to it, or the actual number of pathogens in the host 6 . In this context, resistance is defined as the inverse of the pathogen burden; when resistance increases, the pathogen load will decrease. Tolerance is defined by the slope of the reaction norm; that is, the more tolerant the host, the flatter the slope [7] [8] . In other words, plants that are more tolerant to infection will have a smaller decrease in their overall health as pathogen burden increases compared with less tolerant plants. By using the slope of the relationship between health and pathogen load, it is easy to compare populations that differ in their health before they were infected (a property known as vigour).
This model has much to offer for our understanding of defence mechanisms against pathogens in animals. In vertebrate models of infectious diseases, we rarely carry out such analyses and it is practically impossible to do this for actual patients. However, the logic behind this type of analysis could be useful because resistance and tolerance, as defined in this manner, have exciting ecological and biomedical implications.
This definition of tolerance is not new to studies of vertebrate immunity but it is certainly under-represented. By discussing known examples of tolerance in animals in this article, we hope to reignite interest and encourage a broader application of the concept of tolerance to vertebrate models of infectious disease. First, we speculate on the types of physiology that could be involved in mechanisms of tolerance in animals and discuss evidence indicating that these defensive measures are important in defining the overall health of a host with various types of infection. We then discuss how the concept of tolerance can be studied systematically and how it can be integrated into medical practices.
What are the mechanisms of tolerance?
Immunologists are used to describing resistance mechanisms in an organized manner: an immune recognition event is followed by the production of effectors, which results in interactions between immune cells. By contrast, although immunopathology is a well-known result of an immune response, its discussion is generally organized around the resistance mechanisms that generate the pathology, the organism that is responsible for the disease or the organs that are affected. Organizing A host's health will decrease as microorganisms reproduce and drive pathogen load to higher levels
Immunocompromised hosts cannot limit microbial growth, and this leads to decreased health during infections
The resistance mechanisms of the host will oppose microbial growth and thus maintain health the discussion of tolerance around three different issues can make it difficult to find commonalities between the immunopathological mechanisms that define tolerance. To overcome this problem, we have organized our discussion of tolerance mechanisms by considering the effects that a mechanism has on tolerance and resistance. We define three classes of mechanisms that differ in the strength of the association between resistance and tolerance (FIG. 2) . We consider that a mechanism affects tolerance if it is predicted to decrease or increase the slope of the tolerance curve; it will be important to understand both how to decrease the mechanisms that increase the slope of the tolerance curve and how to augment the mechanisms that flatten the curve.
Class one. The distinguishing characteristic of our first class of mechanisms is that it comprises effector molecules that induce resistance mechanisms that can cause selfharm and as a result decrease tolerance, such that resistance and tolerance are absolutely linked and their effects are opposite. For example, reactive oxygen species that are produced during an immune response are important for fighting infections, but their activity can also induce severe immunopathology and even death in some cases, thereby decreasing tolerance 9, 10 . During evolution, we expect that there has been selection for less toxic effectors and receptors in the immune system; hosts have probably evolved effector molecules, such as antimicrobial peptides (AmPs), that are less toxic to self than to pathogens 11 . A similar selection must have occurred for receptors that trigger immune responses, for example, Toll-like receptors (TlRs), thereby resulting in higher affinity of these receptors for pathogen-associated molecules than for self molecules 12 . This also happens at an individual level over the lifetime of animals that have an adaptive immune response. What most immunologists call tolerance -the elimination of self-reactive T-cell receptors and antibodies -should also increase tolerance according to the ecological definition of this word. In all of these examples, the factor that is required to decrease pathogen load (and thereby increase resistance) is the same factor that causes immunopathology and increases the slope of the tolerance curve (in other words, decreases tolerance).
Class two. In the second class of tolerance mechanisms, we have placed regulators that control both resistance and tolerance. We have separated these from resistance effectors because these signalling molecules do not cause pathology directly, and so it might be possible to separate their effects on resistance and tolerance by selectively blocking specific signalling pathways or signalling in specific tissues. For example, tumournecrosis factor (TnF) is crucial for fighting some infections because it activates immune cells and thus has a pro-resistance function 13 . At the same time, the damage that is induced by effectors of the activated immune cells, as well as additional pathology that is caused by other targets of TnF, will decrease the health of the host and therefore increase the slope of the tolerance curve. These first two classes provide examples of factors that are predicted to show a trade-off between resistance and tolerance.
Class three. Tolerance mechanisms that can be easily separated from resistance mechanisms form a third class. We suggest that this group of mechanisms will provide the most useful candidates when searching for new drugs and treatments that modulate tolerance. We describe five examples here. First, during an immune response to infection, toxic compounds can be produced by the host or pathogen that must be dealt with to prevent damage to the host; for example, the destruction of red blood cells during malaria infection causes free haem (which is toxic to the host) to enter the circulation. Haem oxygenase 1 acts as a detoxifying enzyme of haem 14 , and defects in this pathway would cause a decrease in tolerance.
second, resistance responses can be expensive in terms of energy expenditure, and appropriate energy management is required to fuel these responses without causing irreparable damage to other systems and to leave enough energy for repair. As we discuss in more detail later, the fruit fly Drosophila melanogaster exhibits altered energy use and wasting of the body when infected with Mycobacterium marinum, and this seems to be due to decreased tolerance 15 . Figure 1 | Definitions and implications of resistance and tolerance. A | resistance, which is a measure of the ability of a host to limit pathogen growth and thereby maintain health, can be interpolated from these graphs as the inverse of the mean of the pathogen load. tolerance, which is a measure of the ability of a host to survive an infection at a given pathogen load, is the slope of the curve that relates host health to pathogen load. B | the slope that describes tolerance is not a fixed property and can vary between strains and possibly even during an infection in one individual. shown are three examples of how strains can differ in terms of tolerance and resistance to pathogen infection. Ba | these two strains have similar resistance profiles (mean pathogen load is the same) but the strain shown in blue has stronger tolerance. Bb | In this hypothetical example, the two strains have similar tolerance properties, but the strain shown in blue has weaker resistance. Bc Third, we propose that processes that prevent physiological damage will also affect tolerance. some immune responses can induce physiological changes that are deleterious for some organs. For example, sepsis can induce fatal changes in cardiovascular physiology, including hypercontraction of the heart and altered vascular tone, which must be inhibited to prevent damage and to increase tolerance 16 . The fourth group of repair mechanisms is related to the third group; if pathology can not be entirely prevented, then repair of tissue damage is necessary. For example, infection with the helminth Nippostrongylus brasiliensis in mice causes severe damage to the pulmonary environment during larval migration through the lungs and triggers the production of several factors that are important for lung repair. These factors include elastin, procollagen and matrix metalloproteinases, the production of which results in rapid resolution of the helminth-induced damage 17, 18 . We propose a fifth group of mechanisms, which comprise evolutionary solutions to infection that affect tolerance in a pathogen-specific manner. examples of these evolutionary solutions include the genetic traits that offer increased defences against malaria [19] [20] [21] [22] [23] . We discuss these examples in more detail later. Of course, we expect more examples to be revealed as tolerance mechanisms in animal defences are explored further.
If we consider only pathogenic interactions between bacteria and hosts when defining tolerance mechanisms, we risk missing the large number of non-pathogenic inter actions that occur with bacteria. Interactions with mutualistic and commensal bacteria might reveal more tolerance mechanisms. For example, humans do not normally raise pathological immune responses to lipopolysaccharide (lPs) in the intestinal lumen. Therefore, the human body plan, which sequesters microorganisms to certain regions of the body, could also be considered to be a tolerance mechanism. In addition, the native microbiota forms an integral part of resistance and tolerance mechanisms in humans; if there is a normal intestinal flora, humans can tolerate a certain number of pathogens in the intestines, but this tolerance is decreased if the flora is altered with antibiotics.
In all of these examples, resistance and tolerance are considered to be host properties. However, we know of many virulence factors in bacterial pathogens that affect resistance; so, do pathogens also encode tolerance factors? A good place to look for these might be in mutualistic bacteria or in pathogens that cause chronic infections.
Tolerance mechanisms in invertebrates studies that examine immune-defence systems in invertebrates commonly estimate the genetic contribution to immunity by measuring a single parameter of immunocompetence; for example, pathogen load or antimicrobial activity are used to represent the effects of infection on host fitness [24] [25] [26] . This has been a successful approach, and studies like these led to the dissection of the Toll and immune deficiency (Imd) signalling pathways in D. melanogaster [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] . such studies also led to the observation that flies that lack these two pathways cannot produce AmPs and therefore have high bacterial loads and die rapidly after infection. These studies were based heavily on dissecting the mechanism of immunocompetence (in this case, nuclear-factor-κB-mediated regulation of AmPs) and measured phenotype (survival) only as a secondary characteristic [36] [37] [38] [39] [40] . Approaches that look primarily at phenotypes tell a different story. To better understand the relationship between disease resistance and host fitness, 11 different genotypes of D. melanogaster were infected with Pseudomonas aeruginosa, and the correlation between pathogen burden and host survival was examined 41 . These genotypes varied significantly in terms of both bacterial titres (a measure of resistance) and survival, but there was no correlation between these two parameters; the genotypes that had low bacterial titres were not necessarily the healthiest. This indicates that processes other than resistance are used by D. melanogaster to cope with the stresses of infection, and that tolerance, not resistance, is a crucial determinant of host survival during this type of infection. Furthermore, these results indicate that genetic variation for tolerance exists in invertebrates 41 . Another study examining the mechanism by which M. marinum kills D. melanogaster found that M. marinum infection leads to body wasting, with a progressive loss of fat and glycogen 15 . It seems that M. marinum infection decreases the activation of the insulin effector kinase AkT, resulting in increased forkhead box O (FOXO) transcriptional activity, which drives the wasting process in flies and ultimately leads to death. The authors showed that this wasting could be suppressed by decreasing FOXO activity in the fly, which had no effect on bacterial load but increased the survival of D. melanogaster. Therefore, protection against M. marinum infection was not a resistance effect, but a tolerance effect that was based on altered energy use by the host. This is one of the few examples of a D. melanogaster infection for which the cause of death is known, and it seems to be due to a problem with tolerance rather than due to increased susceptibility to infection or proliferation of the pathogen 15 . The detection of tolerance mechanisms during infections in a genetically tractable organism, such as D. melanogaster, offers promising potential to identify pathways that are involved in regulating these tolerance properties, which might ultimately be translated into biomedical practices. 42 reported the first study that applied the statistical framework of reaction norms developed by plant ecologists to a vertebrate model (FIG. 1) . To measure the variation of tolerance in animals, they infected five strains of mice with P. chabaudi and tested three different clones of P. chabaudi that differed in infection intensity. To measure host health, they recorded the severity of anaemia and weight loss in infected mice. These health indicators were then plotted against peak parasite density, which is indicative of parasite burden. As noted previously, there was significant variation in the degree of resistance between the mouse strains (when comparing peak parasite density). Interestingly, the slopes that were generated from the reaction norms varied between the different mouse strains, which indicates that there is also variation in tolerance between the mouse strains tested. In addition, they observed a negative correlation between tolerance and resistance, which indicates that there is a trade-off between these defence mechanisms. The mechanisms of tolerance in these mice are unknown 42 . The tick-transmitted spirochete Borrelia burgdorferi is the causative agent of lyme disease in humans. In the mouse model of lyme disease, B. burgdorferi causes arthritis that ranges in severity depending on the genetic background of the infected mouse. Both resistance and tolerance mechanisms seem to be important in controlling the development of arthritis, depending on the mouse strain. In one study, BAlB/cAnn mice controlled disease severity by restricting the number of spirochetes in tissues, which indicates that this mouse strain uses resistance mechanisms to control the infection 43 . By contrast, C57Bl/6n mice do not develop severe arthritis regardless of the number of spirochetes that are found in the tissues, which indicates that these mice can better tolerate the pathology of the infection, through unknown mechanisms 43 .
Tolerance properties in vertebrate models
The above examples provide phenotypic evidence of tolerance but are not informative about the tolerance mechanisms that drive them. studies of individual mouse mutants have provided some mechanistic insight into tolerance. For example, mice that are deficient for an ATP-sensitive potassium (k ATP ) channel were found to be more sensitive to lPs. This channel is expressed in coronary arteries, and the mutant mice suffered from heart attacks when challenged with lPs 44 . Additional alleles of the k ATP gene were identified in a screen for mice that have altered susceptibility to murine cytomegalovirus. viral infection of mice that are deficient for the k ATP channel resulted in decreased cytokine production and abrupt death, with no obvious signs of sickness. However, viral titres were comparable to infected wild-type mice, which indicates that the k ATP channel is involved in positively regulating tolerance during infection. The k ATP channel is thought to work by preventing coronaryartery vasoconstriction, which is induced by cytokines that are produced in response to signalling through TlRs or melanoma differentiation-associated gene 5 (mDA5) during some types of infection 45 . In this case, the tolerance mechanism seems to fit in the category of damage prevention.
The phenomenon of lPs tolerance, which is the transient decreased responsiveness to repeated exposure to lPs, is a well-known example of tolerance [46] [47] [48] [49] . Traditionally, lPs tolerance was described as a desensitization of TlRs, which results in macrophages being hyporesponsive to subsequent exposure to lPs [50] [51] [52] . One study examined more closely the effects of lPs tolerance on the expression of genes that are under the control of TlR signalling 53 . The authors proposed that because hundreds of genes of many different functions are controlled by TlRs, it is unlikely that lPs tolerance regulates all of the signals that are transduced by a particular TlR, but instead probably acts in a gene-specific manner. To test this idea they used an in vitro model system for lPs tolerance in mouse macrophages and compared the gene-expression profiles of naive and tolerant macrophages that had been stimulated with lPs. They identified two classes of TlR4-induced genes based on their functions and regulatory requirements. The first class, which included pro-inflammatory cytokines, was silenced in the tolerized macrophages, whereas the second class, which included antimicrobial genes, was not. Regulation of these classes occurs at the level of gene transcription rather than the upstream TlR signal and involves transient chromatin modifications 53 . This study shows that resistance and tolerance properties can occur as separate and distinct mechanisms that are regulated independently of each other.
Tolerance properties in humans malaria exerts evolutionary pressure on humans, and genetic traits that affect resistance or tolerance -such as sickle-cell anaemia, α-thalassaemia and glucose-6-phosphate dehydrogenase (G6PDH) deficiency -have appeared in affected populations. In the case of α-thalassaemia, individuals with the mutation have less severe malarial episodes, and this seems to be due to increased tolerance properties because parasite loads are unaffected 22 . A possible mechanism for the protective effect of α-thalassaemia comes from the observation that there is decreased expression of complement receptor 1 (CR1) on red blood cells from individuals with the disease. As CR1 seems to be involved in rosette formation of red blood cells, which occurs in severe forms of malaria, α + -thalassaemia red blood cells have decreased rosetting and therefore decreased disease severity 22 . The phenomenon of natural antimalarial immunity (known as premunition), in which infected individuals can withstand the presence of parasites in their blood at levels that would elicit sickness in unprotected individuals 54, 55 , was first described 70 years ago. We propose that this might be another example of tolerance in that the body is somehow tolerating the Plasmodium spp. rather than inducing a large immune response that would cause pathology. A recent model to explain this phenomenon involves the desensitization of TlR-mediated signalling, which links antimalarial immunity to lPs tolerance. During a Plasmodium spp. infection, the glycosylphosphatidylinositol (GPI) of the parasite, which is released during lysis of red blood cells, induces a pro-inflammatory response by signalling through TlR2-myD88 (myeloid differentiation primary-response gene 88). This leads to the production of pro-inflammatory cytokines, including TnF, interleukin-1 (Il-1) and Il-6, that are important for controlling the growth of the parasite. When parasite levels and pro-inflammatory-cytokine levels decrease, anti-inflammatory cytokines, including Il-10, are produced. This signalling and cytokine profile is similar to that mediated by TlR4 signalling following lPs stimulation. In fact, more than 40 years ago it was shown that experimentally induced malaria infections in human volunteers resulted in cross-tolerance to the febrile response that is caused by the injection of lPs. Cross-tolerance between TlR2 (activated by GPI) and TlR4 (activated by lPs) has also been shown in vitro 56 . This might indicate the existence of a common tolerance mechanism between antimalarial immunity and lPs tolerance that involves alterations in TlR signalling.
Studying tolerance systematically?
We have described how the defence response in humans and other animals can be broken down into resistance and tolerance mechanisms, but we think that tolerance studies are rare in mammals, whereas resistance studies make up most immunological reports. Of the tolerance mechanisms we do know, many seem to be tightly linked with resistance mechanisms. We argue that current immunological studies that focus on effector mechanisms and signalling between immune cells can find only the types of tolerance mechanism that are tightly integrated in the immunesignalling network. But what about proteins such as the k ATP channel that seem to lie outside of traditional immune signalling? When we limit the scope of our studies to resistance signalling and effector molecules, as is often the case in traditional immunological studies, we miss the outlying tolerance mechanisms, and these are the ones that will probably be most useful in terms of medical intervention because they are less likely to affect resistance to microorganisms
. We need to broaden the focus of our studies and take a holistic approach to understanding the factors that contribute to disease severity. We need methods of identifying tolerance mechanisms that are separable from resistance mechanisms.
Tolerance traits can be determined genetically, and we suggest that these properties should be easy to find by broadening the scope of our assays and measuring tolerance directly. For the past decade, D. melanogaster genetic screens have concentrated on learning how the AmPs that are downstream of the Toll or Imd pathways are regulated. These types of genetic screen are focused on resistance mechanisms, and therefore mutations that affect tolerance mechanisms could be easily missed. We recently published an unbiased forward genetic screen in D. melanogaster that coupled the concepts of resistance and tolerance to identify genes that are involved in the defence against Listeria monocytogenes infection 57 . In this study, we found that in two-thirds of the mutant flies, increased susceptibility to death correlated with increased bacterial burden, which indicates defects in resistance mechanisms. By contrast, the remaining mutant flies died but had comparable levels of bacteria to the wild-type flies, which indicates that these mutants were defective in tolerance mechanisms and could not endure the pathological consequences of the infection. similarly, various candidate-gene knockout studies in mice 14, 58, 59 , in addition to a genetic screen 45 , have shown that studying both disease severity and pathogen burden will reveal the involvement of immune responses in tolerance mechanisms. We should carry out future screens that measure both positive and negative changes in tolerance that are induced by both gain-offunction and loss-of-function mutations. We should also turn to microorganisms for answers in future studies; because of the potential benefits that tolerance mechanisms might have on pathogen infection and transmission, some pathogens might have evolved mechanisms to enhance the tolerance of their hosts.
Of course, genetics is not the entire story and it is important to remember that tolerance traits are also affected by the life history of a host. For example, D. melanogaster suffer from immune senescence during ageing and, in one model, this is due to an age-related loss of tolerance 60 . D. melanogaster that have been injected with a lethal dose of Escherichia coli differ in their death rate depending on their age, but the growth rate of the infecting bacteria remains constant; this indicates a change in tolerance. We should pay attention to epigenetic mechanisms for altering tolerance because these might provide the most rapid route to developing new treatments.
We stress the importance of testing various pathogens when studying tolerance mechanisms, both genetically and epigenetically. In humans, we anticipate that different types of disease -for example, bacterial diarrhoea, pneumonia or sepsis -will have different sets of mechanisms that control tolerance. Indeed, the TnF-family member in D. melanogaster, eiger, has multiple and opposite roles in immune defence, which become clear only when various pathogens are tested 61, 62 . If tolerance is to be modulated medically, we must ensure that while treating one infection we do not make a patient more susceptible to another.
Medicine and tolerance
In current medical practice, doctors can often recognize when the tolerance of a patient must be increased, and the tools that are needed to achieve this are available. For example, patients with cholera die because of severe dehydration, and the first line of treatment for these patients is to administer electrolytes and to keep them hydrated. This increases tolerance by limiting pathology and allows the patients to live long enough to rely on their resistance mechanisms to clear the pathogen. Bacterial meningitis is an example in which we assume that we
Box 1 | Evolutionary implications of resistance and tolerance
Resistance and tolerance are predicted to have different evolutionary effects on the pathogen and host. In the case of resistance, host-pathogen interactions are expected to drive the co-evolution of antagonistic traits 64, 65 . Because resistance mechanisms act by directly limiting pathogen burden, if a host evolves resistance to a particular pathogen, the microorganism will evolve a method to subvert the resistance. This will drive the selection of more resistant traits in the pathogen population that can overcome the resistance mechanisms of the host, which will then drive the natural selection of more effective resistance mechanisms in the host population. This co-evolutionary relationship prevents a resistant trait from becoming fixed within a host population [66] [67] [68] and therefore continues to drive the evolution of host resistance mechanisms. By contrast, these types of selective pressure are not expected to be placed on pathogens owing to the evolution of increased tolerance. As tolerance works by alleviating disease severity, it should have a neutral or possibly positive effect on the pathogen; for example, tolerant hosts might live longer, thereby increasing the prevalence of the disease and potentially altering its spread. Unlike resistance, a tolerance trait will eventually become fixed in a host population because it will be positively selected for. Mechanisms that increase tolerance are not predicted to lead to the development of highly resistant pathogens. Therefore, understanding tolerance mechanisms should provide a good foundation for therapies because microorganisms are not anticipated to develop resistance, and thus the therapy will remain useful for long periods of time. As we discuss in detail in the main text, several tolerance mechanisms are already targeted in medical practice to help fight infections [66] [67] [68] [69] [70] [71] . are increasing the tolerance of a patient by directly manipulating the immune response. When corticosteroids are administered in combination with the initial antibiotic treatment, they significantly decrease the risk of mortality and hearing loss 63 . The goal of this article is not to highlight tolerance as a new way of treating patients. Instead, by using a different description of our defences against infectious diseases, we hope to encourage new experiments to discover more examples of tolerance mechanisms. such findings could then be integrated into our current clinical practices to increase the survival of patients.
The reaction norms that are used by plant ecologists to measure plant health rely on a logic that we propose can be applied to assess patient health. It is impossible to determine a particular patient's reaction norm for tolerance and to use that as a diagnostic tool, but by systematically studying tolerance, we will learn more about the mechanisms that control these properties. This will allow us to develop diagnostic tools to monitor relevant mechanisms and to gain a better sense of tolerance curves for individual patients. using this information, doctors could determine whether patients are sick because their resistance is suboptimal or because their tolerance is low, and choose appropriate treatments on the basis of this knowledge.
The intentional manipulation of resistance would increase health by moving the patient up the reaction-norm curve. This can be accomplished with current medical practices, such as vaccination before the patient encounters the pathogen or administration of antibiotics once the patient becomes ill. The manipulation of tolerance would cause the slope of the curve to change. If the patient's tolerance mechanisms are collapsing, then they will have an extremely steep tolerance curve. The physician needs to rotate the reaction norm back up to its normal position by increasing the tolerance properties of the patient, and as a result increase the patient's health. The manipulation of tolerance is already a common practice in medicine, for example, as we described for cholera and meningitis. As the number of studies that examine tolerance mechanisms increases, we could develop additional drugs and therapeutics that can be used to manipulate a patient's tolerance and shift their tolerance curve to a healthy range (FIG. 3) .
As discussed in BOX 1, ecologists predict that resistance and tolerance will have different evolutionary effects on pathogens. Because host resistance mechanisms place selective pressures on pathogens, microorganisms will eventually evolve mechanisms to subvert resistance. We encounter this problem with many medical treatments that increase host resistance, including antibiotics. As tolerance mechanisms are not expected to have the same selective pressures on pathogens as resistance mechanisms, we suggest that new drugs that target tolerance mechanisms will provide therapies to which pathogens will not develop resistance. The types of tolerance mechanism that could be targeted for drug manipulation should be chosen with caution; the tolerance mechanisms that are tightly linked or inversely related to resistance mechanisms might not be the best candidates for drugs, as their manipulation could affect both resistance and tolerance in unpredictable ways. Tolerance genes that lie Figure 3 | Applications of resistance and tolerance to medical treatment. We propose that every patient has a tolerance curve that describes their health in relation to their pathogen load. the goal of treatment during an infection is to increase the health of the patient. two treatment routes can lead to the same increase in health: by decreasing pathogen load (an increase in resistance), which will push the patient up the reaction norm; or by markedly altering the slope (and possibly shape) of the reaction norm (by increasing tolerance), which could alter health without altering pathogen levels.
